Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Brotchie

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Behavioural Pharmacology|August 1, 1995
Reversal of parkinsonian symptoms by intrastriatal and systemic manipulations of excitatory amino acid and dopamine transmission in the bilateral 6-OHDA lesioned marmosetI J Mitchell, N Hughes, C B Carroll, et al.
European Journal of Pharmacology|July 18, 1996
Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidusY P Maneuf, J E Nash, A R Crossman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Modeling the functional organization of the basal ganglia. A parallel distributed processing approachI J Mitchell, J M Brotchie, G D Brown, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primateJ M Brotchie, I J Mitchell, M A Sambrook, et al.
Experimental Neurology|January 1, 1994
On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidusY P Maneuf, I J Mitchell, A R Crossman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2004
Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's diseaseMonty A Silverdale, S L Nicholson, A R Crossman, et al.
Experimental Neurology|May 19, 2001
Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's diseaseM A Silverdale, S McGuire, A McInnes, et al.
Neurobiology of Disease|April 13, 2001
Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeysE Bezard, P Ravenscroft, C E Gross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's diseaseB Henry, S H Fox, D Peggs, et al.
Parkinsonism & Related Disorders|August 27, 2020
The selective 5-HT<sub>1A</sub> receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaquesR Depoortere, T H Johnston, S H Fox, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Behavioural Pharmacology|August 1, 1995
Reversal of parkinsonian symptoms by intrastriatal and systemic manipulations of excitatory amino acid and dopamine transmission in the bilateral 6-OHDA lesioned marmosetI J Mitchell, N Hughes, C B Carroll, et al.
European Journal of Pharmacology|July 18, 1996
Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidusY P Maneuf, J E Nash, A R Crossman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Modeling the functional organization of the basal ganglia. A parallel distributed processing approachI J Mitchell, J M Brotchie, G D Brown, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primateJ M Brotchie, I J Mitchell, M A Sambrook, et al.
Experimental Neurology|January 1, 1994
On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidusY P Maneuf, I J Mitchell, A R Crossman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 14, 2004
Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's diseaseMonty A Silverdale, S L Nicholson, A R Crossman, et al.
Experimental Neurology|May 19, 2001
Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's diseaseM A Silverdale, S McGuire, A McInnes, et al.
Neurobiology of Disease|April 13, 2001
Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine monkeysE Bezard, P Ravenscroft, C E Gross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's diseaseB Henry, S H Fox, D Peggs, et al.
Parkinsonism & Related Disorders|August 27, 2020
The selective 5-HT<sub>1A</sub> receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaquesR Depoortere, T H Johnston, S H Fox, et al.
Pageof 6